Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Go back to Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.23 -0.01 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.24 | 52 Week High | $19.62 | |||
| Open | $2.22 | 52 Week Low | $7.65 | |||
| Day High | $2.25 | P/E | N/A | |||
| Day Low | $2.19 | EPS | $-0.22 | |||
| Volume | 1,653,330 | |||||
